Sign in

CIK 0001637715 · <br>Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472309515
Phone
(720) 307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,157
in 2 filings

Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 35 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-07 Manke Isaac Director Grant or award · Stock Option (right to buy) +300,000 300,000
2026-08-07 Manke Isaac Director Returned to the company · Stock Option (right to buy) −15,300 0
2026-08-07 Manke Isaac Director Grant or award · Stock Option (right to buy) +15,300 15,300
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −2,359 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +2,359 2,359
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −1,485 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +1,485 1,485
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −8,449 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +8,449 8,449
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −16,898 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +16,898 16,898
2026-08-07 Saccomano Nicholas A President and CEO Returned to the company · Employee Stock Option (right to buy) −542,232 0
2026-08-07 Saccomano Nicholas A President and CEO Grant or award · Employee Stock Option (right to buy) +542,232 542,232
2026-08-07 Ratcliffe Liam Director Grant or award · Stock Option (right to buy) +22,350 22,350
2026-08-07 GREY MICHAEL G Director Grant or award · Stock Option (right to buy) +22,350 22,350
2026-08-07 Mathers Edward T Director Grant or award · Stock Option (right to buy) +22,350 22,350
2026-06-22 Leverone Jason A. Chief Financial Officer Sale −303 $4.40 $1K 18,802
2026-06-22 Saccomano Nicholas A President and CEO Sale −86 $4.40 $378 11,247
2026-06-04 Phillips Andrew John Director Grant or award · Stock Option (right to buy) +7,650 7,650

Page 2 of 8 · 154 trades